Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 5/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | PLAU | P00749 | 1/20 | 0.42 |
| ▸ | HTR2C | P28335 | 1/20 | 0.42 |
| ▸ | HTR2B | P41595 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30717243 | 0.80 | SLC6A4 (0.45) | SLC6A4SLC6A2SLC6A3KDM4ECYP3A4 | |
| SCHEMBL845627 | 0.80 | SLC6A4 (0.45) | SLC6A4SLC6A2SLC6A3KDM4ECYP3A4 | |
| SCHEMBL5852700 | 0.80 | SLC6A4 (0.45) | SLC6A4SLC6A2SLC6A3KDM4ECYP3A4 | |
| SCHEMBL10078444 | 0.75 | SLC6A4 (0.42) | SLC6A4SLC6A2SLC6A3KDM4ECYP3A4 | |
| SCHEMBL19328566 | 0.74 | SLC6A4 (0.41) | SLC6A4SLC6A2SLC6A3KDM4ECYP3A4 | |
| SCHEMBL19328610 | 0.74 | SLC6A4 (0.41) | SLC6A4SLC6A2SLC6A3KDM4ECYP3A4 | |
| SCHEMBL9027488 | 0.74 | SLC6A4 (0.41) | SLC6A4SLC6A2SLC6A3KDM4ECYP3A4 | |
| SCHEMBL19328608 | 0.74 | SLC6A4 (0.41) | SLC6A4SLC6A2SLC6A3KDM4ECYP3A4 | |
| SCHEMBL10399770 | 0.74 | SLC6A4 (0.41) | SLC6A4SLC6A2SLC6A3KDM4ECYP3A4 | |
| SCHEMBL9026171 | 0.74 | SLC6A4 (0.41) | SLC6A4SLC6A2SLC6A3KDM4ECYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100305338-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE CIS-SILYL OLEFIN OXIDE COMPOUND | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-12-02 | — | — | US | disclosed |
| EP-1576089-B1 | EXPANSION OF RENEWABLE STEM CELL POPULATIONS | GAMIDA CELL LTD (IL) | 2010-04-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100305338-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE CIS-SILYL OLEFIN OXIDE COMPOUND | CYP51A1, MSMO1, SQLE | SLC6A4 3755/4885SLC6A2 3995/4885SLC6A3 4196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.